Diagnosing viral infections, using innovative and IVD molecular process, being one step ahead

Our latest symposium presented at the European Society of Clinical Virology (ESCV) 2022 is now available to view on demand.

From the clinical virology laboratory to the point of care and beyond, trusted and flexible molecular solutions keep you at the forefront of diagnostics excellence. The infectious disease landscape is ever‑changing. Outbreaks, emerging and re‑emerging virus, mutations, and growing resistances need sophisticated diagnostic systems and assays to help to provide fast and reliable monitoring. Today, testing consolidation, workflow standardisation, and multiplex molecular solutions are opening new possibilities for diagnostics.

On-demand talks from ESCV 2022

The importance and advantages of multiplex PCR testing for detection and differentiation of respiratory viral pathogens
Jelena Feenstra PhD, Senior Manager, Medical and Scientific Affairs, Thermo Fisher Scientific

High-throughput and automatable virus detection in human clinical samples—expanding beyond the pandemic
Emily Zeringer, Manager, Sample Prep Clinical R&D, Thermo Fisher Scientific

The European regulatory landscape post‑IVDR application
Anna Sadio, EMEA Regulatory Affair Manager, Thermo Fisher Scientific

To access the on-demand talks, please complete and submit the form below.

(*Indicates a mandatory field)

First Name*

Last Name*

Institution*

Job Role*

Please selectAssociateBioinformaticianCEO / COO / PresidentCrime Scene InvestigatorCriminalistDepartment HeadDirectorDNA ExpertEducatorForensic DNA AnalystLab ManagerManagerMedical DoctorPostdoctoral FellowPrincipal InvestigatorProject / Program ManagerPurchaser / ProcurerResearch Assistant / Lab TechnicianSales and MarketingScientist / Associate ScientistSenior Investigating OfficerStudent / Graduate StudentSupervising CriminalistVeterinarianVice PresidentOther

Telephone*

Email*

City*

Country/Region*

Please selectAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaireBosnia & HerzegovinaBotswanaBouvet IslandBrasilBritish Indian OceanBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColumbiaComorosCongoCook IslandsCosta RicaCôte D'IvoireCroatiaCuracaoCyprusCzech RepublicDemocratic Republic of CongoDenmarkDjiboutiDominicaDominican RepublicTIMOR-LESTEEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFederated States of MicronesiaFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuianaGuineaGuinea - BissauHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIraqIrelandIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxemburgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilipinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSan MarinoSão Tomé and PríncipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSaint MaartenSlovakiaSloveniaSolomon IslandsSamoaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUnited KingdomUkraineUnited Arab EmiratesUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin IslandsWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Are you currently using qPCR assays for infectious pathogen detection in your lab?*

Yes

No

Would you like to be contacted by a technical specialist to discuss qPCR solutions and workflows for your lab?*

Yes

No

Submit

For In Vitro Diagnostic Use. Product availability varies by country.